A. Hankard , G. Maalouf , J. Laouni , O. Espitia , C. Agard , H. De Boysson , A. Aouba , K. Sacré , T. Papo , G. Leroux , M. Vautier , A.C. Desbois , F. Domont , A. Le Joncour , A. Mirouse , L. Chiche , Y. Skaff , J. Gaudric , S. Boussouar , A. Redheuil , D. Saadoun
{"title":"孤立性颈动脉血管炎的结果和预后。","authors":"A. Hankard , G. Maalouf , J. Laouni , O. Espitia , C. Agard , H. De Boysson , A. Aouba , K. Sacré , T. Papo , G. Leroux , M. Vautier , A.C. Desbois , F. Domont , A. Le Joncour , A. Mirouse , L. Chiche , Y. Skaff , J. Gaudric , S. Boussouar , A. Redheuil , D. Saadoun","doi":"10.1016/j.jaut.2024.103242","DOIUrl":null,"url":null,"abstract":"<div><h3>Objective</h3><p>To assess the prognosis and outcome of patients with isolated carotid vasculitis.</p></div><div><h3>Methods</h3><p>We performed a retrospective multicenter study of 36 patients (median age at diagnosis was 37 [IQR 27–45] years and 11 [31 %] patients were men) with initial presentation as isolated carotid vasculitis. Study endpoints included vascular complications, relapses, and progression to large vessel vasculitis (i.e. Giant cell arteritis or Takayasu).</p></div><div><h3>Results</h3><p>The most frequent involvement was the left internal carotid artery (39 %), and 81 % had stenosis. After a median follow-up of 32 months [IQR 12–96], 21 (58 %) patients had a vascular event, including 31 % of new onset vascular lesions and 25 % of stroke/transient ischemic attack. Patients with stroke had less carotidynia at diagnosis (33 % vs 74 %, p = 0.046), higher significant carotid stenosis (i.e. > 50 %) (89 % vs. 30 %, p = 0.026) and higher severe carotid stenosis (i.e. >70 %) (67 % vs 19 %, p = 0.012), compared to those without stroke. Twenty (52 %) patients experienced relapses. High CRP at diagnosis was associated with relapses (p = 0.022). At the end of follow-up, 21 (58 %) patients were classified as having Takayasu arteritis, 13 (36 %) as isolated carotid vasculitis, and two (6 %) as giant cell arteritis.</p></div><div><h3>Conclusion</h3><p>Carotid vasculitis may occur as a topographically limited lesion and is associated with significant rate of vascular complications.</p></div>","PeriodicalId":15245,"journal":{"name":"Journal of autoimmunity","volume":"146 ","pages":"Article 103242"},"PeriodicalIF":7.9000,"publicationDate":"2024-05-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S0896841124000763/pdfft?md5=cb72b13f764e26d795452b8a2e83203a&pid=1-s2.0-S0896841124000763-main.pdf","citationCount":"0","resultStr":"{\"title\":\"Outcome and prognosis of isolated carotid vasculitis\",\"authors\":\"A. Hankard , G. Maalouf , J. Laouni , O. Espitia , C. Agard , H. De Boysson , A. Aouba , K. Sacré , T. Papo , G. Leroux , M. Vautier , A.C. Desbois , F. Domont , A. Le Joncour , A. Mirouse , L. Chiche , Y. Skaff , J. Gaudric , S. Boussouar , A. Redheuil , D. Saadoun\",\"doi\":\"10.1016/j.jaut.2024.103242\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><h3>Objective</h3><p>To assess the prognosis and outcome of patients with isolated carotid vasculitis.</p></div><div><h3>Methods</h3><p>We performed a retrospective multicenter study of 36 patients (median age at diagnosis was 37 [IQR 27–45] years and 11 [31 %] patients were men) with initial presentation as isolated carotid vasculitis. Study endpoints included vascular complications, relapses, and progression to large vessel vasculitis (i.e. Giant cell arteritis or Takayasu).</p></div><div><h3>Results</h3><p>The most frequent involvement was the left internal carotid artery (39 %), and 81 % had stenosis. After a median follow-up of 32 months [IQR 12–96], 21 (58 %) patients had a vascular event, including 31 % of new onset vascular lesions and 25 % of stroke/transient ischemic attack. Patients with stroke had less carotidynia at diagnosis (33 % vs 74 %, p = 0.046), higher significant carotid stenosis (i.e. > 50 %) (89 % vs. 30 %, p = 0.026) and higher severe carotid stenosis (i.e. >70 %) (67 % vs 19 %, p = 0.012), compared to those without stroke. Twenty (52 %) patients experienced relapses. High CRP at diagnosis was associated with relapses (p = 0.022). At the end of follow-up, 21 (58 %) patients were classified as having Takayasu arteritis, 13 (36 %) as isolated carotid vasculitis, and two (6 %) as giant cell arteritis.</p></div><div><h3>Conclusion</h3><p>Carotid vasculitis may occur as a topographically limited lesion and is associated with significant rate of vascular complications.</p></div>\",\"PeriodicalId\":15245,\"journal\":{\"name\":\"Journal of autoimmunity\",\"volume\":\"146 \",\"pages\":\"Article 103242\"},\"PeriodicalIF\":7.9000,\"publicationDate\":\"2024-05-17\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.sciencedirect.com/science/article/pii/S0896841124000763/pdfft?md5=cb72b13f764e26d795452b8a2e83203a&pid=1-s2.0-S0896841124000763-main.pdf\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of autoimmunity\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S0896841124000763\",\"RegionNum\":1,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"IMMUNOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of autoimmunity","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0896841124000763","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"IMMUNOLOGY","Score":null,"Total":0}
Outcome and prognosis of isolated carotid vasculitis
Objective
To assess the prognosis and outcome of patients with isolated carotid vasculitis.
Methods
We performed a retrospective multicenter study of 36 patients (median age at diagnosis was 37 [IQR 27–45] years and 11 [31 %] patients were men) with initial presentation as isolated carotid vasculitis. Study endpoints included vascular complications, relapses, and progression to large vessel vasculitis (i.e. Giant cell arteritis or Takayasu).
Results
The most frequent involvement was the left internal carotid artery (39 %), and 81 % had stenosis. After a median follow-up of 32 months [IQR 12–96], 21 (58 %) patients had a vascular event, including 31 % of new onset vascular lesions and 25 % of stroke/transient ischemic attack. Patients with stroke had less carotidynia at diagnosis (33 % vs 74 %, p = 0.046), higher significant carotid stenosis (i.e. > 50 %) (89 % vs. 30 %, p = 0.026) and higher severe carotid stenosis (i.e. >70 %) (67 % vs 19 %, p = 0.012), compared to those without stroke. Twenty (52 %) patients experienced relapses. High CRP at diagnosis was associated with relapses (p = 0.022). At the end of follow-up, 21 (58 %) patients were classified as having Takayasu arteritis, 13 (36 %) as isolated carotid vasculitis, and two (6 %) as giant cell arteritis.
Conclusion
Carotid vasculitis may occur as a topographically limited lesion and is associated with significant rate of vascular complications.
期刊介绍:
The Journal of Autoimmunity serves as the primary publication for research on various facets of autoimmunity. These include topics such as the mechanism of self-recognition, regulation of autoimmune responses, experimental autoimmune diseases, diagnostic tests for autoantibodies, as well as the epidemiology, pathophysiology, and treatment of autoimmune diseases. While the journal covers a wide range of subjects, it emphasizes papers exploring the genetic, molecular biology, and cellular aspects of the field.
The Journal of Translational Autoimmunity, on the other hand, is a subsidiary journal of the Journal of Autoimmunity. It focuses specifically on translating scientific discoveries in autoimmunity into clinical applications and practical solutions. By highlighting research that bridges the gap between basic science and clinical practice, the Journal of Translational Autoimmunity aims to advance the understanding and treatment of autoimmune diseases.